Literature DB >> 30420332

Inhibition of nuclear thioredoxin aggregation attenuates PM2.5-induced NF-κB activation and pro-inflammatory responses.

Zhonghui Zhu1, Xiaowei Chen1, Jingping Sun1, Qiuyue Li1, Ximeng Lian1, Siling Li1, Yan Wang1, Lin Tian2.   

Abstract

Exposure to fine particulate matter (PM2.5) can induce oxidative stress and proinflammatory cytokine production, which are central for the induction of PM2.5-mediated adverse effects on public health. Nuclear factor kappa B (NF-κB) signaling is essential for inflammation. The subcellular distribution of thioredoxin (Trx) is related to the activation of NF-κB, but the mechanism involved is unclear. In the current study, we focused on the relationship between the antioxidant Trx and NF-κB in human bronchial epithelial cells (BEAS-2B) after PM2.5 exposure. We inhibited the nuclear translocation of Trx by cHCEU (4-cyclohexyl-[3-(2-chloroethyl)ureido]benzene) and subsequently increased the transcriptional activity of Nrf2 to upregulate the expression of Trx by t-BHQ. Our data suggest that PM2.5 exposure induces the activation of NF-κB and the expression of the downstream proinflammatory cytokines IL-1, IL-6, IL-8 and TNF-α in BEAS-2B cells. CHCEU alleviates inflammatory cytokines by blocking Trx nuclear translocation and inhibits the DNA binding activity of NF-κB. T-BHQ could promote the transcriptional activity of Nrf2 but failed to alleviate the production of inflammatory cytokines. Furthermore, the synergistic effect of t-BHQ and cHCEU on alleviating PM2.5-induced inflammation is more effective than the use of cHCEU alone. Our findings characterize the underlying molecular mechanisms of proinflammatory responses induced by PM2.5 and show that the nuclear translocation and accumulation of Trx in nuclei play important roles in PM2.5-induced NF-κB activation and proinflammatory responses.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; NF-κB; Nrf2; PM(2.5); Trx

Mesh:

Substances:

Year:  2018        PMID: 30420332     DOI: 10.1016/j.freeradbiomed.2018.10.438

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

1.  microRNA-149-5p mediates the PM2.5-induced inflammatory response by targeting TAB2 via MAPK and NF-κB signaling pathways in vivo and in vitro.

Authors:  Qiuyue Li; Siling Li; Chunjie Xu; Jing Zhao; Lin Hou; Fuyang Jiang; Zhonghui Zhu; Yan Wang; Lin Tian
Journal:  Cell Biol Toxicol       Date:  2021-07-31       Impact factor: 6.691

2.  Thioredoxin 1 is upregulated in the bone and bone marrow following experimental myocardial infarction: evidence for a remote organ response.

Authors:  José R Godoy; Sarah Pittrich; Svetlana Slavic; Christopher Horst Lillig; Eva-Maria Hanschmann; Reinhold G Erben
Journal:  Histochem Cell Biol       Date:  2020-11-08       Impact factor: 4.304

Review 3.  Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases.

Authors:  Haruka Tsubaki; Ikuo Tooyama; Douglas Gordon Walker
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

4.  Metabolic Response to Tick-Borne Encephalitis Virus Infection and Bacterial Co-Infections.

Authors:  Marta Dobrzyńska; Anna Moniuszko-Malinowska; Iwona Jarocka-Karpowicz; Piotr Czupryna; Monika Groth; Elżbieta Skrzydlewska
Journal:  Pathogens       Date:  2022-03-23

5.  Particulate matter 2.5 triggers airway inflammation and bronchial hyperresponsiveness in mice by activating the SIRT2-p65 pathway.

Authors:  Manling Liu; Zhaoling Shi; Yue Yin; Yishi Wang; Nan Mu; Chen Li; Heng Ma; Qiong Wang
Journal:  Front Med       Date:  2021-06-28       Impact factor: 4.592

6.  Promoting Nrf2/Sirt3-Dependent Mitophagy Suppresses Apoptosis in Nucleus Pulposus Cells and Protects against Intervertebral Disc Degeneration.

Authors:  Sunli Hu; Chenxi Zhang; Tianchen Qian; Yue Bai; Liang Chen; Jiaoxiang Chen; Chongan Huang; Chenglong Xie; Xiangyang Wang; Haiming Jin
Journal:  Oxid Med Cell Longev       Date:  2021-06-09       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.